BioCentury
ARTICLE | Clinical News

IMA950: Phase I data

May 12, 2014 7:00 AM UTC

immatics reported data from an open-label, U.K. Phase I trial in 45 patients with newly diagnosed glioblastoma showing that IMA950 plus standard of care (SOC) surgery and concomitant or adjuvant chemo...